Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
Your comments are welcome:
submit feedback
|
|
Account summary |
|
Search detail for: |
Park Street Strategies, LLC
|
Registration year: |
2019 |
Registration type:
|
Lobbyist Entity
|
Address:
|
15 Clifton Avenue Marblehead, MA, 01945 USA / 617-981-0015
|
Lobbyist information
|
Amount
|
Total salaries paid:
$0.00
|
|
Client information
|
Amount
|
Biotechnology Innovation Organization (BIO)
|
$40,000.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2019
|
|
All Legislation and Executive Branch activities in the Commonwealth including, but not limited to, agriculture, health care, taxation, and other issues pertaining to biotechnology
|
|
Flexion Therapeutics, Inc.
|
$60,000.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2019
|
|
All matters related to the treatment of patients with musculoskeletal conditions, such as osteoarthritis and issues related to non-opioid treatments for pain management.
|
|
Massachusetts Biotechnology Council
|
$120,000.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2019
|
|
Any and all legislation and regulations pertaining to the healthcare system; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth; implementation of Chapter 224 the Acts of 2012, health care reform, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, Massachusetts Life Sciences Center, research and development, taxation policies, drug safety, recycling and disposal policies green bio policies. Any and all legislation, regulation, policy matters before the legislature or executive branch including the Executive Offices of the Governor and Lieutenant Governor, Executive Office of Health & Human Services, Department of Public Health, Division of Insurance, MassHealth and related matters to the Office of the Attorney General, Center for Health Information and Analysis and the Health Policy Commission.
|
|
Shire
|
$30,000.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2019
|
06/30/2019
|
Legislative, budgetary, and regulatory matters affecting the health care, life sciences, pharmaceutical, and medical device industry.
|
|
UCB, Inc.
|
$42,000.00
|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
01/01/2019
|
|
Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors/markets in the Commonwealth; any laws or regulations that impose or levy taxes upon a biopharmaceutical company doing business in the Commonwealth; any laws or regulations which provided incentives or disincentives to biopharmaceutical companies conducting research in the Commonwealth; and, any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth's Medicaid or other publicly funded and reimbursed programs
|
|
Total salaries received:
$292,000.00
|
|
|
Operating Expenses
|
$8,242.43
|
Meal, Entertainment, and Travel Expenses
|
$743.32
|
Total expenses:
$8,985.75
|
Disclosure Report details
|
|
|
|
|